Linda Cota

TL;DR: THV thrombosis is a rare phenomenon that was detected within the first 2 years after transcatheter aortic valve implantation and usually presented with dyspnea and increased gradients, and anticoagulation seems to have been effective and should be considered even in patients without visible thrombus on echocardiography.

TL;DR: Combined use of DA and DCB may represent a potential alternative strategy for the treatment of femoro-popliteal severely calcified lesions and very promising data and the considered hypothesis have to be confirmed in a multicentre randomised trial.

TL;DR: The data suggest that adjunctive use of drug-eluting balloons for the treatment of SFA-ISR represents a potentially safe and effective therapeutic strategy and should be considered hypothesis-generating to design a randomized trial.

TL;DR: As the use of TAVI becomes widespread, the operators should be aware of this dangerous complication in their case preparation should it arise and perform an aortography at the time of balloon valvuloplasty to identify patients at risk for coronary obstructions.

TL;DR: A transcatheter closure via a surgical transapical approach (TAp) approach appears to be a safe and effective therapeutic option in selected high-risk patients with PVL and is associated with a lower hospital mortality than surgical treatment, in spite of higher predicted risk.